Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Immune-globulin: Lack of efficacy: case reportReactions weekly, 2023-05 (1958), p.272-272Copyright Springer Nature B.V. May 27, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
2 |
Material Type: Article
|
Multiple drugs: Lack of efficacy: case reportReactions weekly, 2023-05 (1958), p.364-364Copyright Springer Nature B.V. May 27, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
3 |
Material Type: Article
|
Azacitidine/durvalumab: Various toxicities: case reportReactions weekly, 2023-05 (1957), p.76-76Copyright Springer Nature B.V. May 20, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
4 |
Material Type: Article
|
Ampicillin/sulbactam Lack of efficacy: case reportReactions weekly, 2023-02 (1944), p.54-54Copyright Springer Nature B.V. Feb 18, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
5 |
Material Type: Article
|
Nivolumab/pembrolizumab/prednisone: Guillain-Barre-syndrome, Miller Fisher syndrome and lack of efficacy: 3 case reportsReactions weekly, 2022-11 (1933), p.353-353Copyright Springer Nature B.V. Nov 19, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
6 |
Material Type: Article
|
Albendazole: Lack of efficacy: case reportReactions weekly, 2022-10 (1930), p.22-22Copyright Springer Nature B.V. Oct 29, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
7 |
Material Type: Article
|
AZD-1222: Guillain-Barre-syndrome: case reportReactions weekly, 2022-10 (1926), p.113-113Copyright Springer Nature B.V. Oct 1, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
8 |
Material Type: Article
|
Immune-globulin/nitrous-oxide: Myeloneuropathy following drug abuse and lack of efficacy : case reportReactions weekly, 2022-09 (1922), p.318-318Copyright Springer Nature B.V. Sep 3, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
9 |
Material Type: Article
|
Immune-globulin: Lack of efficacy: case reportReactions weekly, 2022-07 (1916), p.226-226Copyright Springer Nature B.V. Jul 23, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
10 |
Material Type: Article
|
Eculizumab: Diabetes insipidus: case reportReactions weekly, 2022-06 (1911), p.194-194Copyright Springer Nature B.V. Jun 18, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
11 |
Material Type: Article
|
Bortezomib: Guillain-Barre-syndrome: case reportReactions weekly, 2022-04 (1901), p.136-136Copyright Springer Nature B.V. Apr 9, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
12 |
Material Type: Article
|
AZD-1222: Guillain-Barre syndrome: case reportReactions weekly, 2022-01 (1889), p.74-74Copyright Springer Nature B.V. Jan 15, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
13 |
Material Type: Article
|
BCG: Guillain-Barre Syndrome: case reportReactions weekly, 2022-01 (1888), p.98-98Copyright Springer Nature B.V. Jan 8, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
14 |
Material Type: Article
|
Tolvaptan: No response: case reportReactions weekly, 2022-01 (1887), p.646-646Copyright Springer Nature B.V. Jan 1, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
15 |
Material Type: Article
|
Levetiracetam: Lack of efficacy: case reportReactions weekly, 2023-06 (1959), p.366-366Copyright Springer Nature B.V. Jun 3, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
16 |
Material Type: Article
|
Multiple drugs Lack of efficacy: case report2Reactions weekly, 2021-11 (1880), p.272-272Copyright Springer Nature B.V. Nov 6, 2021 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
17 |
Material Type: Article
|
Azathioprine/immune-globulin/prednisone: Lack of efficacy: case reportReactions weekly, 2021-10 (1878), p.99-99Copyright Springer Nature B.V. Oct 23, 2021 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
18 |
Material Type: Article
|
Nelarabine: Guillain-Barre syndrome: case reportReactions weekly, 2021-10 (1876), p.258-258Copyright Springer Nature B.V. Oct 9, 2021 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
19 |
Material Type: Article
|
Streptokinase Guillain-Barre syndrome: case reportReactions weekly, 2023-03 (1947), p.363-363Copyright Springer Nature B.V. Mar 11, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |
|
20 |
Material Type: Article
|
Immune-globulin Lack of efficacy: case reportReactions weekly, 2023-02 (1944), p.305-305Copyright Springer Nature B.V. Feb 18, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051Full text available |